AGILE THERAPEUTICS INC Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Agile Therapeutics Inc quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Agile Therapeutics Inc Cost of Revenue for the quarter ending June 30, 2024 was $1.5M, a 35.2% decline year-over-year.
  • Agile Therapeutics Inc Cost of Revenue for the twelve months ending June 30, 2024 was $7.84M, a 6.17% increase year-over-year.
  • Agile Therapeutics Inc annual Cost of Revenue for 2023 was $8.98M, a 31.3% increase from 2022.
  • Agile Therapeutics Inc annual Cost of Revenue for 2022 was $6.84M, a 36.2% decline from 2021.
  • Agile Therapeutics Inc annual Cost of Revenue for 2021 was $10.7M, a 3701% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.98M +$2.14M +31.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.84M -$3.88M -36.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $10.7M +$10.4M +3701% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $282K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.